Phoenix Holdings Ltd. Oncocyte Corp Transaction History

Phoenix Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$1.38 - $2.63 $437,650 - $834,072	-317,138 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$1.2 - $1.89 $29,835 - $46,991	24,863 Added 8.51%	317,138 $426,000
Q2 2020 Aug 10, 2020	BUY	$1.91 - $3.45 $53,881 - $97,324	28,210 Added 10.68%	292,275 $597,000
Q1 2020 May 20, 2020	BUY	$1.76 - $3.02 $464,754 - $797,476	264,065 New	264,065 $628,000

1.5M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $338M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.